David Cragg - 01 Jun 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Chief HR & Admin Officer
Signature
David W. Cragg
Issuer symbol
CYTK
Transactions as of
01 Jun 2021
Transactions value $
-$229,896
Form type
4
Filing time
02 Jun 2021, 16:45:38 UTC
Next filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $41.3K +6.56K +4.07% $6.30* 168K 01 Jun 2021 Direct F1, F2
transaction CYTK Common Stock Sale -$142K -6.56K -3.91% $21.63 161K 01 Jun 2021 Direct F1, F2
transaction CYTK Common Stock Options Exercise $53.2K +8.44K +5.23% $6.30* 170K 01 Jun 2021 Direct F1, F2
transaction CYTK Common Stock Sale -$182K -8.44K -4.97% $21.63 161K 01 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (right to buy) Options Exercise $0 -8.44K -100% $0.00* 0 01 Jun 2021 Common Stock 8.44K $6.30 Direct F1
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -6.56K -100% $0.00* 0 01 Jun 2021 Common Stock 6.56K $6.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021.
F2 Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.